- Lobbying
- Lobbying by The Medicines Company
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Patricia DeLoatche | Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, and Legislative Assistant, Rep. Mike Bilirakis |
Dora Hughes | Deputy Directory of Health, HELP, Sen. Edward Kennedy; Health Policy Advisor, Sen. Barrack Obama; Counselor for Science and Public Health, HHS |
William Sarraille | n/a |
Stephanie Hales | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Antibiotics development as it relates to various legislative proposals and agency rulemaking activities.
Termination
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: 340B as it related to the Veterans Health Care Act of 1992, Pub. L. No. 102-585 602, 106 Stat. 4943, 4967-4971 (1992).
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate